Anticipation occurs in familial Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Wiernik, PH [1 ]
Wang, SQ [1 ]
Hu, XP [1 ]
Marino, P [1 ]
机构：
[1] MONTEFIORE MED CTR,ALBERT EINSTEIN CANC CTR,BRONX,NY 10467
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3964 / 3964
页数：1
相关论文
共 50 条
  • [31] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Christiaan Schiepers
    Jean-Emmanuel Filmont
    Johannes Czernin
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S82 - S88
  • [32] PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma
    Hoskin, P. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 : S37 - S41
  • [33] Thalidomide and low dose vinblastine as palliative therapy for patients relapsing after autotransplant for Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
    Game, M
    Coso, D
    Sturgeon, J
    Crump, M
    Keating, A
    BLOOD, 2001, 98 (11) : 365B - 365B
  • [34] Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    O'Connor, OA
    Kelly, W
    Wang, ES
    Richon, V
    Moskowitz, C
    Tong, W
    Donnelly, G
    Zelenetz, AD
    Moore, MAS
    Rifkind, RA
    Marks, PA
    BLOOD, 2001, 98 (11) : 611A - 611A
  • [35] Increased occurrence of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) in families with hereditary nonpolyposis colorectal cancer, HNPCC (Lynch syndrome)
    Teruya-Feldstein, J
    Cohen, L
    Ellis, N
    Greene, J
    Offit, K
    MODERN PATHOLOGY, 2001, 14 (01) : 180A - 180A
  • [36] Phase II clinical study of bortezomib (VELCADE®) in patients (pts) with relapsed refractory non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD).
    Strauss, SJ
    Maharaj, L
    Stec, J
    Boral, A
    Trehu, E
    Schenkein, D
    Joel, SP
    Lister, TA
    BLOOD, 2004, 104 (11) : 389A - 389A
  • [37] Increased occurrence of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) in families with hereditary nonpolyposis colorectal cancer, HNPCC (Lynch syndrome)
    Teruya-Feldstein, J
    Cohen, L
    Ellis, N
    Greene, J
    Offit, K
    LABORATORY INVESTIGATION, 2001, 81 (01) : 180A - 180A
  • [38] Image-guided core-needle biopsy (CNB) in the management of patients with non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
    Chassagne-Clement, C.
    Ranchere, D.
    Thiesse, P.
    Callet-Bauchu, E.
    Bergeron, C.
    Biron, P.
    Ghesquieres, H.
    Sebban, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 250 - 250
  • [39] Anemia associated with non platinum chemotherapy (CT) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL)
    Coiffier, B
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S331 - S331
  • [40] Anticipation in familial Hodgkin's disease
    Shugart, YY
    O'Connell, J
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1417 - 1420
12345